S. U. Bozkurt Et Al. , "IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS," 22nd Congress of the European-Hematology-Association , vol.102, Madrid, Spain, pp.806-807, 2017
Bozkurt, S. U. Et Al. 2017. IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS. 22nd Congress of the European-Hematology-Association , (Madrid, Spain), 806-807.
Bozkurt, S. U., Gecgel, F., Atagunduz, I., Agyol, Y., Turkoz, K., & Tuglular, T., (2017). IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS . 22nd Congress of the European-Hematology-Association (pp.806-807). Madrid, Spain
Bozkurt, SÜHEYLA Et Al. "IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS," 22nd Congress of the European-Hematology-Association, Madrid, Spain, 2017
Bozkurt, SÜHEYLA Et Al. "IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS." 22nd Congress of the European-Hematology-Association , Madrid, Spain, pp.806-807, 2017
Bozkurt, S. U. Et Al. (2017) . "IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS." 22nd Congress of the European-Hematology-Association , Madrid, Spain, pp.806-807.
@conferencepaper{conferencepaper, author={SÜHEYLA BOZKURT Et Al. }, title={IMMUNOHISTOCHEMICAL ANALYSIS OF CALRETICULIN MUTATIONS IN PRIMARY MYELOFIBROSIS (PRMF) PATIENTS: RESULTS OF OUR INSTITUTION IN THE JAK2V617F MUTATED AND JAK2V617F WILD TYPE PRMF PATIENTS}, congress name={22nd Congress of the European-Hematology-Association}, city={Madrid}, country={Spain}, year={2017}, pages={806-807} }